Frontiers in Pharmacology (Jul 2024)
Corrigendum: Ginsenoside Re attenuates high glucose-induced RF/6A injury via regulating PI3K/AKT inhibited HIF-1a/VEGF signaling pathway
Abstract
No abstracts available.Keywords
Frontiers in Pharmacology (Jul 2024)